Oryzon Genomics SA (ORYZF) Stock Price, Quote, News & History

ORYZFOTCPK
$3.34
At close: Apr 20, 5:00 PM EST
Loading...

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 2.67K
Day Range
- - -
52 Wk Range
3.03 - 4.38
Market Cap
$263.37M
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
999.99

Recent Oryzon Genomics SA News

No news found

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-2.36M
Investing Cash Flow (TTM)
-11.04M
Financing Cash Flow (TTM)
36.13M
Free Cash Flow (TTM)
-13.40M
Capital Expenditure (TTM)
-11.04M
Net Change in Cash (TTM)
22.74M

Valuation Metrics

Enterprise Value
$234.99M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.87
Earnings Yield % (TTM)
-1.18%
Earnings Yield % (FWD)
-4.37%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.79

Company Debt

Total Debt
$7.60M
LT Debt
$3.07M
LT Debt Issuance (TTM)
$14.49M
LT Debt Repayment (TTM)
-$6.68M
Total Cash
$28.35M
Debt to Equity
0.06
Issuance of Debt (TTM)
$7.81M
Repayment of Debt (TTM)
-$11.37M

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 2.67K
Day Range
- - -
52 Wk Range
3.03 - 4.38
Market Cap
$263.37M
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
999.99

About

Sector
Health Care
Industry
Biotechnology
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cance...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Oryzon Genomics (ORYZF) stock?

A

You can purchase shares of Oryzon Genomics (OTCPK:ORYZF) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Oryzon Genomics (ORYZF) competitors?

A

There are no as such competitors for Oryzon Genomics.

Q

What is the forecast, or price target, for Oryzon Genomics (ORYZF) stock?

A

There is no analysis for Oryzon Genomics to provide a consensus price target.

Q

What is the current price for Oryzon Genomics (ORYZF)?

A

The stock price for Oryzon Genomics (OTCPK: ORYZF) is $3.34 last updated March 18, 2026 at 11:07 AM EDT.

Q

Does Oryzon Genomics (ORYZF) pay a dividend?

A

There are no upcoming dividends for Oryzon Genomics.

Q

When is Oryzon Genomics (OTCPK:ORYZF) reporting earnings?

A

Oryzon Genomics does not have any upcoming earnings scheduled.

Q

Is Oryzon Genomics (ORYZF) going to split?

A

There is no upcoming split for Oryzon Genomics.

Q

What sector and industry does Oryzon Genomics (ORYZF) operate in?

A

Oryzon Genomics is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.